Medicine
Losortan Potassium 50 mg tablet
Losortan Potassium 50 mg tablet is a prescription medicine containing Losartan for oral use, marketed by AvPAK, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Losartan
- Brand
- Losortan Potassium
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 50 blister pack, 30 tablets, 60 tablets and 1 more
- Marketing authorisation holder
- AvPAK
- Manufacturers
- AvPAKProficient Rx
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA01 Losartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 October 2010
- Identifiers
- RxCUI 979480, 979485, 979492DailyMed set ID a6cd0b5f-2bd6-bed9-e053-2995a90a3191, 364fe10e-11ca-4ee6-9f67-c85dec09aca5NDC 50268-505, 63187-071Application ANDA078243
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 blister pack in 1 box / 1 tablet, film coated in 1 blister pack | 50268-505-15 | AvPAK | 29 May 2020 |
| 30 tablet, film coated in 1 bottle | 63187-071-30 | Proficient Rx | 30 April 2014 |
| 60 tablet, film coated in 1 bottle | 63187-071-60 | Proficient Rx | 30 April 2014 |
| 90 tablet, film coated in 1 bottle | 63187-071-90 | Proficient Rx | 30 April 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 April 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Losartan 50 mg tablet.
Other strengths and forms of Losartan
Clinical summary
Losartan is an angiotensin 2 receptor blocker indicated for treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old, among other approved uses. It is available as tablets and oral suspension. MedsAcross supplies Losartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LosartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- COZAAR prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
Need Losortan Potassium 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.